Israel China Biotechnology (ICB) Ltd. engages in investments in biomedical companies and in research and development of equipment for diagnosing heart diseases. It operates through the Electrocardiogram segment and the Investments segment. The Electrocardiogram segment engages in the development, manufacture, and marketing of technologies and systems for diagnosing ischemic heart diseases. The Investments segment engages in investments in medical companies. The company was founded on November 15, 1999 and is headquartered in Tel Aviv, Israel.
Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!